BRPI0914624A2 - probióticos, iga secretória e infecção - Google Patents

probióticos, iga secretória e infecção

Info

Publication number
BRPI0914624A2
BRPI0914624A2 BRPI0914624A BRPI0914624A BRPI0914624A2 BR PI0914624 A2 BRPI0914624 A2 BR PI0914624A2 BR PI0914624 A BRPI0914624 A BR PI0914624A BR PI0914624 A BRPI0914624 A BR PI0914624A BR PI0914624 A2 BRPI0914624 A2 BR PI0914624A2
Authority
BR
Brazil
Prior art keywords
probiotics
infection
secretory iga
secretory
iga
Prior art date
Application number
BRPI0914624A
Other languages
English (en)
Inventor
Blaise Corthesy
Jalil Benyacoub
Laurent Favre
Stéphanie Blum-Sperisen
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39832407&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0914624(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of BRPI0914624A2 publication Critical patent/BRPI0914624A2/pt
Publication of BRPI0914624B1 publication Critical patent/BRPI0914624B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Pediatric Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
BRPI0914624-5A 2008-06-24 2009-06-16 Uso de uma composição que compreende iga secretora e pelo menos um probiótico, e composição alimentícia BRPI0914624B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08158833.7 2008-06-24
EP08158833A EP2138187A1 (en) 2008-06-24 2008-06-24 Probiotics, secretory IgA and infection
PCT/EP2009/057474 WO2009156307A1 (en) 2008-06-24 2009-06-16 Probiotics, secretory iga and infection

Publications (2)

Publication Number Publication Date
BRPI0914624A2 true BRPI0914624A2 (pt) 2015-10-20
BRPI0914624B1 BRPI0914624B1 (pt) 2021-11-09

Family

ID=39832407

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0914624-5A BRPI0914624B1 (pt) 2008-06-24 2009-06-16 Uso de uma composição que compreende iga secretora e pelo menos um probiótico, e composição alimentícia

Country Status (11)

Country Link
US (3) US9173937B2 (pt)
EP (3) EP2138187A1 (pt)
JP (1) JP2011525484A (pt)
CN (2) CN105816875A (pt)
AU (1) AU2009264423B2 (pt)
BR (1) BRPI0914624B1 (pt)
CA (1) CA2727303A1 (pt)
ES (2) ES2616334T3 (pt)
PL (2) PL2700411T3 (pt)
PT (2) PT2700411T (pt)
WO (1) WO2009156307A1 (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2138186A1 (en) 2008-06-24 2009-12-30 Nestec S.A. Probiotics, secretory IgA and inflammation
JP2012180304A (ja) * 2011-03-01 2012-09-20 Biseibutsu Kagaku Kenkyusho:Kk 鶏のカンピロバクター感染を制御するための飲料
CN103997899B (zh) 2011-06-20 2016-04-20 H.J.亨氏公司 益生菌组合物和方法
RU2654705C2 (ru) 2012-06-18 2018-05-22 Г.Дж. Хайнц Компани Брэндс ЛЛК Глютенозависимые расстройства
US9458230B2 (en) 2013-01-04 2016-10-04 Wisconsin Alumni Research Foundation Secretory IGA compositions, methods of making and methods of use thereof
BR112015028164B1 (pt) 2013-05-10 2022-02-08 H.J. Heinz Company Brands Llc Usos da bactéria probiótica, lactobacillus paracasei, para tratar uma infecção microbiana e para prevenir ou reduzir a gravidade de uma infecção microbiana
US9468674B2 (en) 2013-09-24 2016-10-18 Wisconsin Alumni Research Foundation Methods of use of secretory IgA
CN104473292A (zh) * 2014-12-22 2015-04-01 威海百合生物技术股份有限公司 一种婴幼儿益生菌固体饮料
WO2018220416A1 (en) * 2017-05-31 2018-12-06 Compagnie Gervais Danone Lactobacillus paracasei strain capable of improving the immune response to a viral-bacterial coinfection
TWI731209B (zh) * 2018-01-09 2021-06-21 柯順議 益生菌組合物及其用途
EP3955941A4 (en) * 2019-04-17 2023-04-19 NUtech Ventures COMPOSITIONS WITH NOVEL MICROBES WITH INCREASED PERSISTENCE, SYNERGISTIC COMBINATIONS OF NOVEL MICROBES AND PREBIOTICS
EP3990485A1 (en) * 2019-06-28 2022-05-04 Société des Produits Nestlé S.A. COMPOSITIONS COMPRISING SECRETORY IgA AND PROBIOTICS
US20220248738A1 (en) * 2019-07-26 2022-08-11 Evolve Biosystems, Inc. NUTRITIVE COMPOSITIONS WITH SECRETED IgA, MILK FAT GLOBULE MEMBRANE COMPONENTS AND/OR BIFIDOBACTERIUM
EP4034145A4 (en) * 2019-09-24 2023-10-11 The Regents of the University of California BENEFICIAL BACTERIA AND SECRETORY IMMUNOGLOBULIN A
WO2021219786A1 (en) 2020-04-30 2021-11-04 Gottfried Himmler Anti-toxin secretory iga2 preparation
TWI823060B (zh) * 2021-02-26 2023-11-21 豐華生物科技股份有限公司 提升口腔免疫球蛋白a含量及抑制口腔病原菌之組成物及其用途
WO2023118197A1 (en) * 2021-12-20 2023-06-29 Société des Produits Nestlé S.A. Secretory iga-biotic complexes and uses thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5589233A (en) * 1978-12-28 1980-07-05 Shogo Nakano Preparation of additive for breeding of new born cattle
JP2968374B2 (ja) 1991-05-16 1999-10-25 株式会社ヤクルト本社 ＩｇＡ産生促進剤
JPH06234647A (ja) 1993-02-12 1994-08-23 Yakult Honsha Co Ltd ＩｇＡ産生促進剤およびその製造法
JP3269890B2 (ja) * 1993-08-25 2002-04-02 株式会社ヤクルト本社 ワクチンの効果増強剤及び効果増強食品
US5531988A (en) * 1994-10-28 1996-07-02 Metagenics, Inc. Bacteria and immunoglobulin-containing composition for human gastrointestinal health
AUPN698495A0 (en) * 1995-12-06 1996-01-04 Pharma Pacific Pty Ltd Improved therapeutic formulation and method
US6616927B2 (en) * 1997-05-29 2003-09-09 Agresearch Limited Processes for production of immunoglobulin A in milk
EP0904784A1 (en) * 1997-09-22 1999-03-31 N.V. Nutricia Probiotic nutritional preparation
EP1446023B1 (en) * 2001-11-12 2009-02-25 Mars, Incorporated Foodstuff for cats and dogs
CA2535362C (en) * 2003-08-21 2013-03-19 Otsuka Pharmaceutical Co., Ltd. Lactic acid bacteria capable of stimulating mucosal immunity
US7943124B2 (en) * 2005-02-02 2011-05-17 Meiji Dairies Corporation Composition for immunostimulation
DK1879908T3 (da) * 2005-05-10 2014-03-31 Murray Goulburn Coop Co Ltd Immunoglobulinfraktion og fremgangsmåde hertil
MX2008002222A (es) * 2005-08-19 2008-03-25 Unilever Nv Productos alimenticios que comprende microorganismos probioticos y anticuerpos.
US20080145420A1 (en) * 2006-12-13 2008-06-19 Simon Michael R HUMAN SECRETORY IgA FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE ASSOCIATED DISEASES
EP2138186A1 (en) 2008-06-24 2009-12-30 Nestec S.A. Probiotics, secretory IgA and inflammation
JP5589233B2 (ja) 2011-08-24 2014-09-17 株式会社 ｌｉｆｅ ｐａｒｋ． ｂｉｚ 消火器の基台

Also Published As

Publication number Publication date
AU2009264423A1 (en) 2009-12-30
PT2700411T (pt) 2017-03-29
US9173937B2 (en) 2015-11-03
EP2318047B2 (en) 2018-08-15
ES2477882T5 (es) 2018-11-07
US20120014963A1 (en) 2012-01-19
ES2477882T3 (es) 2014-07-18
EP2318047A1 (en) 2011-05-11
ES2616334T3 (es) 2017-06-12
PL2318047T3 (pl) 2014-10-31
CN105816875A (zh) 2016-08-03
PT2318047E (pt) 2014-06-24
AU2009264423B2 (en) 2014-01-16
EP2700411B1 (en) 2016-12-28
US9629908B2 (en) 2017-04-25
BRPI0914624B1 (pt) 2021-11-09
EP2138187A1 (en) 2009-12-30
EP2700411A1 (en) 2014-02-26
US20170281757A1 (en) 2017-10-05
EP2318047B1 (en) 2014-05-14
JP2011525484A (ja) 2011-09-22
US20160106834A1 (en) 2016-04-21
PL2700411T3 (pl) 2017-06-30
CN102076361A (zh) 2011-05-25
CA2727303A1 (en) 2009-12-30
WO2009156307A1 (en) 2009-12-30

Similar Documents

Publication Publication Date Title
BRPI0914624A2 (pt) probióticos, iga secretória e infecção
BRPI0914561A2 (pt) probióticos, iga secretória e inflamação
BRPI1010574A2 (pt) cereal infantil compreendendo micro-organismos probióticos não replicantes.
BRPI0921919A2 (pt) dispositivos médicos, aparelhos, sistemas e métodos
BRPI0907231A2 (pt) pirrolpirimidinas e pirrolpiridinas
BRPI0909770A2 (pt) Vacina, e, kit
BRPI0913752A2 (pt) método, dispositivo, e, estrutura
BRPI0816771A2 (pt) Espaçador interespinhal
BRPI0814467A2 (pt) Método, e, biocombustível
BR112012002877A2 (pt) dilatador e conjunto.
FI20070245A0 (fi) Hissijärjestelmä
BRPI0922486A2 (pt) microcápsulas e suas respectivas utilizações
BRPI1006030A2 (pt) reclinador de banco, e, banco
BRPI1009824A2 (pt) dispersão sólida e forma farmacêutica sólida.
FI20070903A (fi) Hissijärjestelmä
DK2240203T3 (da) Alfa5-beta1-antistoffer og deres anvendelser
DK2328931T3 (da) Selektive anti-hepcidin-25-antistoffer og anvendelser deraf
BRPI1013338A2 (pt) processos e intermediários
FI20090093A (fi) Taittopyöräjärjestely, hissi ja menetelmä
BRPI0912350A2 (pt) circuito de interface, e, interface
BRPI1015915A2 (pt) dispositivo para fabricação de vidro laminado e método de fabricação de vidro laminado.
BRPI0905071A2 (pt) Sistema e terminal
BRPI0920294A2 (pt) dispositivos formando controlador central e formando periférico distante, e, sistema
BRPI1008596A2 (pt) sistema, e, aparelho
FI20106126A (fi) Kuvantaja

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NAO 10196/2001, QUE MODIFICOU A LEI NAO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUAANCIA PRA VIA DA ANVISA. CONSIDERANDO A APROVAA AO DOS TERMOS DO PARECER NAO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NAO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDAANCIAS CABA-VEIS.

B25A Requested transfer of rights approved

Owner name: SOCIETE DES PRODUITS NESTLE S.A. (CH)

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 16/06/2009, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO.